✦ LIBER ✦

Prolonged intermittent oral topotecan in patients with refractory and/or advanced malignancies

✍ Scribed by Suzanne F. Jones, John G. Kuhn, F. Anthony Greco…

Book ID: 120840523
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Tongue: English
Weight: 107 KB
Volume: 3
Category: Article
ISSN: 0099-7374
DOI: 10.2165/00024669-200403050-00005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of interferon-α and isotretinoi

Activity of interferon-α and isotretinoin in patients with advanced, refractory lymphoid malignancies

✍ Apostolia-Maria Tsimberidou; Francis Giles; Jorge Romaguera; Madeleine Duvic; Ra 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract ## BACKGROUND Interferon‐α (IFN‐α) and retinoids have shown nonoverlapping toxicity and each has shown antitumor activity in patients with lymphoma. The aim of the current study was to assess the toxicity, safety, and efficacy of IFN‐α combined with isotretinoin in patients with advanc

Phase I study of intermittent and chrono

Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer

✍ Daniele Santini; Bruno Vincenzi; Gaia Schiavon; Annalisa La Cesa; Simona Gasparr 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 246 KB

Phase-I dose escalation and sequencing s

Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies

✍ James A. Posey; Hui Wang; JoElle Hamilton; Alma Delgrosso; Ruiwen Zhang; Timothy 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 251 KB

Oral topotecan: Bioavailability, pharmac

Oral topotecan: Bioavailability, pharmacokinetics and impact of ABCG2 genotyping in Chinese patients with advanced cancers

✍ Li, Ning; Song, Yuanyuan; Du, Ping; Shen, Yinchen; Yang, Jianliang; Gui, Lin; Wa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 974 KB

217 PUBLICATION Phase I of intermittent

217 PUBLICATION Phase I of intermittent chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Phase II Study of Intravenous DX-8951f i

Phase II Study of Intravenous DX-8951f in Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer Refractory to Platinum, Taxane, and Topotecan

✍ C. F. VERSCHRAEGEN; C. LEVENBACK; M. VINCENT; J. WOLF; M. BEVERS; E. LOYER; A. P 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB